Results 11 to 20 of about 107,538 (247)

Uveitis output in high-impact clinical ophthalmology journals: a bibliometric analysis [PDF]

Journal of Ophthalmic Inflammation and Infection
Background Despite uveitis subspecialty workforce shortages, uveitis specialists remain engaged in research. This study examines the relationship between the proportions of uveitis-focused articles in high-impact ophthalmology journals and fellowship ...
Baotram V. Nguyen, Priyanka Bhatnagar, Daniel C. Lee, Meghan K. Berkenstock   +3 more
doaj   +2 more sources

The Clinical Spectrum and Outcomes of Ocular Syphilis in Saudi Arabia: The Emergence of a Uveitic Masquerader [PDF]

Journal of Epidemiology and Global Health
This retrospective multicenter cohort study aimed to describe the clinical features and report the outcomes of the management of ocular syphilis in Saudi Arabia.
Abrar A. Alhawsawi, Abeer Aljahdali, Enas Magharbil, Asma Alzuabi, Abdulrahman F. Albloushi, Dhoha Alhamad, Abrar K. Alsalamah, Sulaiman M. Alsulaiman, Fatimah Al Hammad, Moustafa S. Magliyah, Hassan A. Al-Dhibi   +10 more
doaj   +2 more sources

Cytokines in uveitis [PDF]

Current Opinion in Ophthalmology, 2018
Increasing evidence supports Th17 cells as key mediators of ocular inflammatory disease. Cytokines that are important for the development and pathologic function of these cells are potential therapeutic targets in patients with immune mediated uveitis.
Kathryn L. Pepple, Jessica E. Weinstein
openaire   +4 more sources

Uveitis and Other Ocular Complications Following COVID-19 Vaccination

Journal of Clinical Medicine, 2021
Coronavirus disease 2019 (COVID-19) vaccines can cause transient local and systemic post-vaccination reactions. The aim of this study was to report uveitis and other ocular complications following COVID-19 vaccination.
E. Bolletta, Danilo Iannetta, V. Mastrofilippo, L. de Simone, F. Gozzi, S. Croci, M. Bonacini, L. Belloni, A. Zerbini, C. Adani, L. Fontana, C. Salvarani, L. Cimino   +12 more
semanticscholar   +1 more source

Progress in the genetics of uveitis

Genes and Immunity, 2022
Uveitis is the most common form of intraocular inflammatory disease and is a significant cause of visual impairment worldwide. Aetiologically, uveitis can also be classified into infectious uveitis and non-infectious uveitis.
Xiu-Feng Huang, M. Brown
semanticscholar   +1 more source

Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review

Frontiers in Medicine, 2021
Purpose: Non-infectious uveitis is a leading cause of vision loss in the developed world. The purpose of this systematic review is to investigate the epidemiology and risk factors of non-infectious uveitis over the last 50 years.
K. Joltikov, Ann-Marie Lobo-Chan
semanticscholar   +1 more source

Uveitis: Molecular Pathogenesis and Emerging Therapies

Frontiers in Immunology, 2021
The profound impact that vision loss has on human activities and quality of life necessitates understanding the etiology of potentially blinding diseases and their clinical management.
C. Egwuagu, S. Alhakeem, E. Mbanefo
semanticscholar   +1 more source

Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings

Frontiers in Immunology, 2021
Uveitis is a generic term for inflammation of the uvea, which includes the iris, ciliary body, and choroid. Prevalence of underlying non-infectious uveitis varies by race and region and is a major cause of legal blindness in developed countries. Although
M. Takeuchi, N. Mizuki, S. Ohno
semanticscholar   +1 more source

Cytomegalovirus retinitis in patients of non-Hodgkin’s lymphoma: clinical presentations and outcomes

Journal of Ophthalmic Inflammation and Infection, 2021
Background Cytomegalovirus (CMV) retinitis in patients with Non-Hodgkin’s Lymphoma (NHL) can occur even in the presence of high CD 4 counts and can behave differently when compared to CMV retinitis in human immunodeficiency (HIV) patients. It, therefore,
Subhakar Reddy, Mudit Tyagi, Shashwat Behera, Rajeev R. Pappuru, Vivek P. Dave, Soumyava Basu, Hitesh Agrawal   +6 more
doaj   +1 more source

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

Trials, 2021
Background Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease and the most common systemic disorder associated with uveitis in childhood.
A. Ramanan, C. Guly, S. Keller, D. Schlichting, S. de Bono, R. Liao, P. Quartier   +6 more
semanticscholar   +1 more source